$1 - $2 ... lets worry about getting above 10c first.
management have a history of spending more than they make look at PAP, retractable needle - these were "company making" wastes of time and money really.
Lets focus on getting a run on the board with Artimist before worrying about nicosorb. the last annoucement merely indicated they were reviewing nicosorb - there is no indication as to when this is supposed to hit the markets and/or what further testing is required?
the coffee, page-42
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.728M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 65378 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 274450 | 2 |
View Market Depth
| Last trade - 16.12pm 09/08/2024 (20 minute delay) ? |
| EMS (ASX) Chart |
Day chart unavailable